Proton pump inhibitors affect the gut microbiome

The Inappropriate Prescription of Oral Proton Pump Inhibitors in the Hospital Setting: A Prospective Cross-Sectional Study

(2015) Orlaith B. Kelly et al.   DIGESTIVE DISEASES AND SCIENCES

Burden of Clostridium difficile Infection in the United States

(2015) Fernanda C. Lessa et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cohort profile: LifeLines DEEP, a prospective, general population cohort study in the northern Netherlands: study design and baseline characteristics

(2015) Ettje F Tigchelaar et al.   BMJ Open

Continuous Proton Pump Inhibitor Therapy and the Associated Risk of RecurrentClostridium difficileInfection

(2015) Emily G. McDonald et al.   JAMA Internal Medicine

Compact graphical representation of phylogenetic data and metadata with GraPhlAn

(2015) Francesco Asnicar et al.   PeerJ

Human Genetics Shape the Gut Microbiome

(2014) Julia K. Goodrich et al.   CELL

Potential association between the recent increase in campylobacteriosis incidence in the Netherlands and proton-pump inhibitor use – an ecological study

(2014) M Bouwknegt et al.   Eurosurveillance

Role of the Intestinal Microbiota in Resistance to Colonization by Clostridium difficile

(2014) Robert A. Britton et al.   GASTROENTEROLOGY

Cohort Profile: LifeLines, a three-generation cohort study and biobank

(2014) Salome Scholtens et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile

(2014) Charlie G. Buffie et al.   NATURE

Multistate Point-Prevalence Survey of Health Care–Associated Infections

(2014) Shelley S. Magill et al.   NEW ENGLAND JOURNAL OF MEDICINE

Gastric microbiota is altered in oesophagitis and Barrett's oesophagus and further modified by proton pump inhibitors

(2013) Itay Amir et al.   ENVIRONMENTAL MICROBIOLOGY

Mixed infection by Clostridium difficile in an in vitro model of the human gut

(2013) S. D. Baines et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Intestinal Dysbiosis and Depletion of Butyrogenic Bacteria in Clostridium difficile Infection and Nosocomial Diarrhea

(2013) V. C. Antharam et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Control of pathogens and pathobionts by the gut microbiota

(2013) Nobuhiko Kamada et al.   NATURE IMMUNOLOGY

The Gordian Knot of dysbiosis, obesity and NAFLD

(2013) Wajahat Z. Mehal   Nature Reviews Gastroenterology & Hepatology

Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile

(2013) Els van Nood et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clostridium difficile-Associated Diarrhea and Proton Pump Inhibitor Therapy: A Meta-Analysis

(2012) Sailajah Janarthanan et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Succession in the Gut Microbiome following Antibiotic and Antibody Therapies for Clostridium difficile

(2012) Gregory L. Peterfreund et al.   PLoS One

Composition of the adult digestive tract bacterial microbiome based on seven mouth surfaces, tonsils, throat and stool samples

(2012) Nicola Segata et al.   GENOME BIOLOGY

Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment

(2012) Xochitl C Morgan et al.   GENOME BIOLOGY

Clostridium difficile Carriage in Elderly Subjects and Associated Changes in the Intestinal Microbiota

(2011) M. C. Rea et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Stop the killing of beneficial bacteria

(2011) Martin Blaser   NATURE

Clostridium difficile infection: new developments in epidemiology and pathogenesis

(2009) Maja Rupnik et al.   NATURE REVIEWS MICROBIOLOGY

Human gut microbiota in obesity and after gastric bypass

(2009) H. Zhang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Decreased Diversity of the Fecal Microbiome in RecurrentClostridium difficile–Associated Diarrhea

(2008) Ju Young Chang et al.   JOURNAL OF INFECTIOUS DISEASES